Please assess the completion status of the following clinical trial:

Trial Title: Field Trial of Maternal Influenza Immunization in Asia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* mid to late pregnancy~Exclusion Criteria:~* do not intend to deliver in the study area~* previous pregnancy in this study

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- influenza vaccine (Type: EXPERIMENTAL): Pregnant women assigned to the intervention group will receive one dose of seasonal influenza vaccine at the time of enrollment. The vaccine that will be given will be the current seasonal influenza recommended vaccine at the time of enrollment.
- saline placebo (Type: PLACEBO_COMPARATOR): Pregnant women assigned to the control group will receive one dose of placebo (normal saline).

Based on this trial design, predict the completion outcome and termination type (if applicable).